Overview
Primary lateral sclerosis (PLS) is a progressive neurological disorder characterized primarily by upper motor neuron (UMN) dysfunction without significant lower motor neuron (LMN) involvement or muscle atrophy. Unlike amyotrophic lateral sclerosis (ALS), PLS predominantly affects the corticospinal tracts (CST), leading to spasticity, hyperreflexia, and stiffness, particularly in the limbs. The clinical course of PLS is often slower than that of ALS, with patients typically experiencing prolonged survival. Diagnosis can be challenging due to overlapping symptoms with other UMN syndromes, necessitating careful clinical evaluation and imaging studies to differentiate PLS from conditions like hereditary spastic paraplegia or cervical spondylosis. Understanding the nuances of PLS is crucial for appropriate management and prognostic counseling.
Clinical Presentation
The clinical presentation of primary lateral sclerosis (PLS) typically manifests with progressive spasticity and hyperreflexia, predominantly affecting the limbs. Patients often report difficulty with gait, characterized by a stiff, scissor-like gait pattern, and may experience clumsiness or clumsiness in fine motor tasks. A notable case described a 62-year-old woman who presented with early-stage motor neuron disease likely diagnosed as PLS, exhibiting macroglossia—an enlarged tongue that hindered full mouth closure—significant sialorrhea, and challenges in chewing solid foods [PMID:31307259]. These symptoms highlight the variability in clinical manifestations, extending beyond limb involvement to include bulbar symptoms, which can significantly impact quality of life. Additionally, patients may experience urinary urgency or incontinence due to bladder dysfunction secondary to UMN involvement. Early recognition of these diverse symptoms is essential for timely intervention and management.
Diagnosis
Diagnosing primary lateral sclerosis (PLS) involves a combination of clinical assessment and advanced imaging techniques to differentiate it from other UMN syndromes. Magnetic resonance imaging (MRI) plays a pivotal role, particularly in identifying characteristic changes in the corticospinal tracts (CST). Studies have shown that early CST hyperintensity on FLAIR sequences can indicate initial axonal degeneration with increased water content, underscoring the importance of longitudinal MRI studies for monitoring disease progression [PMID:41951265]. Interestingly, normalization of CST hyperintensity over 5–15 years has been observed in some patients, despite ongoing clinical symptoms, suggesting that imaging findings may not always correlate directly with clinical stability [PMID:41951265]. This dynamic nature of imaging changes highlights the need for systematic visual scoring methods, which have proven effective in documenting these changes and are valuable tools in clinical practice for tracking disease evolution [PMID:41951265].
In addition to imaging, functional scales are crucial for assessing disease progression and response to treatment. The Primary Lateral Sclerosis Functional Rating Scale (PLSFRS) has been translated and validated into Spanish, demonstrating excellent inter- and intrarater reliability (ICC = 0.90-1.00) for total scores and most subdomains [PMID:41175083]. This reliability supports its use in clinical settings for consistent assessment of PLS progression, facilitating standardized monitoring across different healthcare providers and settings. Clinicians should consider both clinical examination findings and validated scales to ensure a comprehensive diagnosis and ongoing evaluation of PLS.
Management
The management of primary lateral sclerosis (PLS) focuses on alleviating symptoms, improving quality of life, and monitoring disease progression. Given the variability in symptom presentation, a multidisciplinary approach is often necessary, involving neurologists, physical therapists, occupational therapists, and speech therapists. Non-invasive ventilation has emerged as a supportive intervention, particularly in patients with bulbar involvement or respiratory complications. For instance, a patient with macroglossia and nocturnal respiratory issues experienced normalization of EtCO2 levels following the initiation of non-invasive ventilation in pressure control mode [PMID:31307259]. This underscores the importance of addressing respiratory complications proactively to prevent nocturnal hypercapnia and desaturation, which can significantly impact patient comfort and safety.
Functional scales like the Spanish PLSFRS provide reliable tools for clinicians to monitor functional impairment over time. The substantial agreement between in-clinic and over-the-phone assessments using PLSFRS indicates its utility in facilitating remote monitoring and follow-up care, ensuring consistent management even when face-to-face visits are limited [PMID:41175083]. Physical therapy interventions aimed at reducing spasticity and improving mobility, such as botulinum toxin injections and selective dorsal rhizotomy, can also be beneficial. Additionally, medications like baclofen or tizanidine may be prescribed to manage spasticity, although their efficacy can vary among patients. Regular reassessment and adjustment of the management plan based on functional scales and patient feedback are crucial for optimizing outcomes in PLS.
Complications
Patients with primary lateral sclerosis (PLS) face several potential complications that can significantly affect their quality of life and functional independence. One notable complication is nocturnal hypercapnia and desaturation, often exacerbated by bulbar symptoms such as macroglossia. In a reported case, a patient exhibited these respiratory issues, which were successfully managed with the introduction of non-invasive ventilation, leading to normalized EtCO2 levels [PMID:31307259]. This intervention highlights the critical need for vigilant monitoring of respiratory function, particularly in patients with bulbar involvement, to prevent acute respiratory events.
Other complications include urinary dysfunction, such as urgency and incontinence, secondary to UMN involvement affecting bladder control. Additionally, progressive spasticity can lead to contractures and joint deformities, necessitating regular physical therapy and possibly surgical interventions like tendon lengthening or release. Cognitive changes, although less common than in ALS, can occur and may require neuropsychological assessment and support. Comprehensive management should address these multifaceted complications to maintain optimal function and comfort for patients throughout the disease course.
Prognosis & Follow-up
The prognosis for primary lateral sclerosis (PLS) generally offers a more favorable outlook compared to other motor neuron diseases, with patients often experiencing prolonged survival periods. Longitudinal imaging studies have provided valuable insights into disease progression, revealing that normalization of CST hyperintensity over extended periods (5–15 years) may indicate a transition from active axonal degeneration to chronic gliosis [PMID:41951265]. This evolving understanding suggests that imaging biomarkers could serve as important tools for monitoring disease dynamics and predicting clinical stability or changes.
Regular follow-up is essential for tracking both clinical symptoms and imaging findings. Clinicians should utilize validated scales like the PLSFRS to systematically assess functional decline or improvement, ensuring that management strategies are adjusted accordingly. The extended survival characteristic of PLS patients offers a unique opportunity for conducting long-term studies, capturing complex patterns of CST signal evolution and refining prognostic models. Continuous monitoring not only aids in tailoring individualized care plans but also in providing patients and families with realistic expectations regarding disease progression and potential future interventions. Regular multidisciplinary team evaluations can further enhance the quality of care and support provided to PLS patients over time.
References
1 Marques Couto C, Gomes SAMC, Carvalho RS, Nascimento OJ. Disappearing corticospinal tract on routine MRI: dynamic signal evolution in primary lateral sclerosis. BMJ case reports 2026. link 2 Caravaca Puchades A, Povedano Panadés M, Bea Sintes M, Domínguez Rubio R, Paipa A. Spanish adaptation of the Primary Lateral Sclerosis Functional Rating Scale (PLSFRS). Amyotrophic lateral sclerosis & frontotemporal degeneration 2026. link 3 Chang MC, Kwak S. Macroglossia in primary lateral sclerosis: a case report. The International journal of neuroscience 2019. link